Leukocyte Count Predictor of Future Long COVID Severity in Postmenopausal Women

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 29, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 29, 2025 -- Leukocyte count is an independent predictor of future postacute sequelae of severe acute respiratory coronavirus 2 infection (PASC) in postmenopausal women, according to a study published online Jan. 28 in Menopause.

Ted K.S. Ng, Ph.D., from Rush University Medical Center in Chicago, and colleagues examined the association of leukocyte count and high-sensitivity C-reactive protein (hsCRP) concentrations measured about 25 years prior to the COVID-19 pandemic with PASC, PASC severity (defined as the sum of PASC symptoms), and PASC-associated cognitive outcomes among postmenopausal women. Multivariable regression models were constructed using biomarker data from blood specimens collected during prepandemic enrollment (1993 to 1998) and data on 1,237 Women's Health Initiative participants who completed a COVID-19 survey between June 2021 and February 2022.

After controlling for baseline characteristics, the researchers identified positive associations between logc-transformed leukocyte count and leukocyte count ≥5.5 x 1,000 cells/µL with PASC severity (β = 0.27 and 0.13, respectively), but not with PASC occurrence or PASC-related cognitive outcomes. Only about 27 percent of participants had data on hsCRP concentration, which was not associated with any of the PASC outcomes.

"Our study extends the evidence that low-grade inflammation is not only a correlate or an outcome of PASC severity, but also precedes the acute COVID-19 infection leading to this debilitating outcome, further supporting a role of inflammation in the etiology of PASC," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-30 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords